SPRO

Spero Therapeuti

• Simply Wall St·05/15 11:05

  Promising Penny Stocks To Consider In May 2026

• Benzinga·05/13 21:15

  Spero Therapeutics Q1 EPS $(0.13) Beats $(0.18) Estimate, Sales $258.000K Down From $5.874M YoY

• Reuters·05/13 20:24

  Spero Therapeutics Q1 revenue drops on decreased clinical activity

• PUBT·05/13 20:15

  Spero Therapeutics Q1 FY26 net loss narrows to $7.2 million; revenue falls to $258,000

• Dow Jones·05/13 20:05

  Press Release: Spero Therapeutics Announces First -2-

• Dow Jones·05/13 20:05

  Press Release: Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update

• Seeking Alpha·05/13 14:00

  Here are the major earnings after the close Wednesday

• PUBT·05/05 20:22

  Spero Therapeutics updates financial calendar with first-quarter results release date

• PUBT·04/13 21:27

  Spero Therapeutics announces annual shareholder meeting webcast

• Simply Wall St·03/28 00:26

  Spero Therapeutics (SPRO) Earnings Turn Positive Challenging Bearish Profitability Narratives

• Reuters·03/26 20:22

  Spero Therapeutics Q4 revenue nearly triples, swings to profit

• Reuters·03/26 20:22

  CORRECTED-Spero Therapeutics Q4 revenue nearly triples, swings to profit

• Seeking Alpha·03/26 20:09

  Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M

• Reuters·03/26 20:07

  Spero Therapeutics FY2025 net income swings to $8.6 million; revenue rises 39.2% to $66.8 million

• Benzinga·03/26 20:06

  Spero Therapeutics Q4 EPS $0.53 Beats $(0.40) Estimate, Sales $41.297M Up From $15.044M YoY